CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance at Dec. 31, 2022	$ 224,519	$ 9	$ 690,753	$ (468)	$ (465,775)
Balance, Shares at Dec. 31, 2022		93,093,243
Stock-based compensation	10,029		10,029
Issuance of common stock, upon vesting of restricted stock, Shares		334,747
Unrealized (loss) gain on available-for-sale securities	167			167
Net Income (Loss)	(41,183)				(41,183)
Balance at Mar. 31, 2023	193,532	$ 9	700,782	(301)	(506,958)
Balance, Shares at Mar. 31, 2023		93,427,990
Balance at Dec. 31, 2022	224,519	$ 9	690,753	(468)	(465,775)
Balance, Shares at Dec. 31, 2022		93,093,243
Unrealized (loss) gain on available-for-sale securities	243
Net Income (Loss)	(86,450)
Balance at Jun. 30, 2023	229,113	$ 11	781,552	(225)	(552,225)
Balance, Shares at Jun. 30, 2023		113,716,018
Balance at Mar. 31, 2023	193,532	$ 9	700,782	(301)	(506,958)
Balance, Shares at Mar. 31, 2023		93,427,990
Stock-based compensation	10,288		10,288
Issuance of common stock, upon vesting of restricted stock, Shares		179,092
Purchase of common stock under the 2020 Employee Stock Purchase Plan	315		315
Purchase of common stock under the 2020 employee stock purchase plan, Shares		108,936
Issuance of common stock in public offering, net of underwriting discounts, commissions and offering costs	70,169	$ 2	70,167
Issuance of common stock in public offering, net of underwriting discounts, commissions and offering costs, Shares		20,000,000
Unrealized (loss) gain on available-for-sale securities	76			76
Net Income (Loss)	(45,267)				(45,267)
Balance at Jun. 30, 2023	229,113	$ 11	781,552	(225)	(552,225)
Balance, Shares at Jun. 30, 2023		113,716,018
Balance at Dec. 31, 2023	145,781	$ 11	802,025	(62)	(656,193)
Balance, Shares at Dec. 31, 2023		114,148,991
Stock-based compensation	5,034		5,034
Issuance of common stock, upon vesting of restricted stock, Shares		732,774
Unrealized (loss) gain on available-for-sale securities	(76)			(76)
Net Income (Loss)	(30,299)				(30,299)
Balance at Mar. 31, 2024	120,440	$ 11	807,059	(138)	(686,492)
Balance, Shares at Mar. 31, 2024		114,881,765
Balance at Dec. 31, 2023	145,781	$ 11	802,025	(62)	(656,193)
Balance, Shares at Dec. 31, 2023		114,148,991
Unrealized (loss) gain on available-for-sale securities	(77)
Net Income (Loss)	(36,375)
Balance at Jun. 30, 2024	120,292	$ 11	812,988	(139)	(692,568)
Balance, Shares at Jun. 30, 2024		115,312,411
Balance at Mar. 31, 2024	120,440	$ 11	807,059	(138)	(686,492)
Balance, Shares at Mar. 31, 2024		114,881,765
Stock-based compensation	5,908		5,908
Issuance of common stock, upon vesting of restricted stock, Shares		394,309
Purchase of common stock under the 2020 Employee Stock Purchase Plan	21		21
Purchase of common stock under the 2020 employee stock purchase plan, Shares		36,337
Unrealized (loss) gain on available-for-sale securities	(1)			(1)
Net Income (Loss)	(6,076)				(6,076)
Balance at Jun. 30, 2024	$ 120,292	$ 11	$ 812,988	$ (139)	$ (692,568)
Balance, Shares at Jun. 30, 2024		115,312,411